Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Crystal structure and functional characterization of an immunomodulatory salivary cystatin from the soft tick Ornithodoros moubata

J. Salát, G.C. Paesen, P. Řezáčová, M. Kotsyfakis, Z. Kovářová, M. Šanda, J. Majtán, L. Grunclová, H. Horká, J.F. Andersen, J. Brynda, M. Horn, M.A. Nunn, P. Kopácek, J. Kopecký, M. Mareš

. 2010 ; 429 (1) : 103-12.

Language English Country England, Great Britain

Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't

The saliva of blood-feeding parasites is a rich source of peptidase inhibitors that help to overcome the host's defence during host-parasite interactions. Using proteomic analysis, the cystatin OmC2 was demonstrated in the saliva of the soft tick Ornithodoros moubata, an important disease vector transmitting African swine fever virus and the spirochaete Borrelia duttoni. A structural, biochemical and biological characterization of this peptidase inhibitor was undertaken in the present study. Recombinant OmC2 was screened against a panel of physiologically relevant peptidases and was found to be an effective broad-specificity inhibitor of cysteine cathepsins, including endopeptidases (cathepsins L and S) and exopeptidases (cathepsins B, C and H). The crystal structure of OmC2 was determined at a resolution of 2.45 A (1 A=0.1 nm) and was used to describe the structure-inhibitory activity relationship. The biological impact of OmC2 was demonstrated both in vitro and in vivo. OmC2 affected the function of antigen-presenting mouse dendritic cells by reducing the production of the pro-inflammatory cytokines tumour necrosis factor alpha and interleukin-12, and proliferation of antigen-specific CD4+ T-cells. This suggests that OmC2 may suppress the host's adaptive immune response. Immunization of mice with OmC2 significantly suppressed the survival of O. moubata in infestation experiments. We conclude that OmC2 is a promising target for the development of a novel anti-tick vaccine to control O. moubata populations and combat the spread of associated diseases.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025645
003      
CZ-PrNML
005      
20221005161844.0
007      
ta
008      
120817s2010 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1042/bj20100280 $2 doi
035    __
$a (PubMed)20545626
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Salát, Jiří $7 xx0105109 $u Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic, Branisovská 31, 37005 Ceské Budejovice, Czech Republic.
245    10
$a Crystal structure and functional characterization of an immunomodulatory salivary cystatin from the soft tick Ornithodoros moubata / $c J. Salát, G.C. Paesen, P. Řezáčová, M. Kotsyfakis, Z. Kovářová, M. Šanda, J. Majtán, L. Grunclová, H. Horká, J.F. Andersen, J. Brynda, M. Horn, M.A. Nunn, P. Kopácek, J. Kopecký, M. Mareš
520    9_
$a The saliva of blood-feeding parasites is a rich source of peptidase inhibitors that help to overcome the host's defence during host-parasite interactions. Using proteomic analysis, the cystatin OmC2 was demonstrated in the saliva of the soft tick Ornithodoros moubata, an important disease vector transmitting African swine fever virus and the spirochaete Borrelia duttoni. A structural, biochemical and biological characterization of this peptidase inhibitor was undertaken in the present study. Recombinant OmC2 was screened against a panel of physiologically relevant peptidases and was found to be an effective broad-specificity inhibitor of cysteine cathepsins, including endopeptidases (cathepsins L and S) and exopeptidases (cathepsins B, C and H). The crystal structure of OmC2 was determined at a resolution of 2.45 A (1 A=0.1 nm) and was used to describe the structure-inhibitory activity relationship. The biological impact of OmC2 was demonstrated both in vitro and in vivo. OmC2 affected the function of antigen-presenting mouse dendritic cells by reducing the production of the pro-inflammatory cytokines tumour necrosis factor alpha and interleukin-12, and proliferation of antigen-specific CD4+ T-cells. This suggests that OmC2 may suppress the host's adaptive immune response. Immunization of mice with OmC2 significantly suppressed the survival of O. moubata in infestation experiments. We conclude that OmC2 is a promising target for the development of a novel anti-tick vaccine to control O. moubata populations and combat the spread of associated diseases.
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a zvířata $7 D000818
650    _2
$a krystalizace $7 D003460
650    _2
$a krystalografie rentgenová $7 D018360
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a imunologické faktory $x chemie $x fyziologie $7 D007155
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C3H $7 D008809
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši transgenní $7 D008822
650    _2
$a molekulární sekvence - údaje $7 D008969
650    _2
$a Ornithodoros $x chemie $x imunologie $7 D026861
650    _2
$a slinné cystatiny $x chemie $x fyziologie $7 D055333
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Paesen, Guido C.
700    1_
$a Řezáčová, Pavlína $7 xx0119409
700    1_
$a Kotsyfakis, Michalis
700    1_
$a Kovářová, Zuzana $7 xx0216688
700    1#
$a Šanda, Miloslav. $7 xx0210970
700    1_
$a Majtán, Juraj $7 xx0106600
700    1#
$a Grunclová, Lenka, $d 1977- $7 jcu2012700732
700    1#
$a Horká, Helena. $7 stk2008405625
700    1_
$a Andersen, John F $7 gn_A_00006077
700    1_
$a Brynda, Jiří $7 xx0100180
700    1#
$a Horn, Martin. $7 xx0279197
700    1_
$a Nunn, Miles A
700    1#
$a Kopáček, Petr, $d 1958- $7 _AN030739
700    1_
$a Kopecký, Jan, $d 1950- $7 jx20051102023
700    1_
$a Mareš, Michael, $d 1961- $7 xx0063697
773    0_
$w MED00009308 $t Biochemical journal $x 1470-8728 $g Roč. 429, č. 1 (2010), s. 103-12
856    41
$u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523712/ $y plný text volně přístupný
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20221005161839 $b ABA008
999    __
$a ok $b bmc $g 947687 $s 782991
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 429 $c 1 $d 103-12 $i 1470-8728 $m Biochemical journal (London. 1984) $n Biochem J $x MED00009308
LZP    __
$a Pubmed-20120817/10/03

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...